|Debt, 2/12 ||$2.2M|
|Debt, 7/12 ||$1.2M|
VBI is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. VBIâ€™s innovative approach to vaccine development and growing pipeline of vaccine programs address significant market opportunities and are designed to answer critical unmet medical needs.
Founded in 2001, VBI is a privately held company headquartered in Cambridge, Massachusetts, with research facilities in Ottawa, Canada. The companyâ€™s investors include Clarus Ventures, ARCH Venture Partners and 5AM Ventures.